6-K
Akanda Corp. (AKAN)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TORULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2024
Commission File Number: 001-41324
AKANDA CORP.
(Name of registrant)
1a, 1b Learoyd Road
New Romney TN28 8XU, United Kingdom
(Address ofprincipal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
| ☒ Form 20-F | ☐ Form 40-F |
|---|
EXHIBIT INDEX
On May 13, 2024, Akanda Corp. (the “Company”) issued a press release titled “Akanda Corp Announces Settlement Agreement With Former CEO Tejinder Virk”, a copy of which is furnished herewith as Exhibit 99.1 to this Report on Form 6-K.
The press release furnished in this report as Exhibit 99.1 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section.
| Exhibit No. | Description |
|---|---|
| 99.1 | Press Release, dated May 13, 2024. |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AKANDA CORP. | |||
|---|---|---|---|
| (Registrant) | |||
| Date: May 13, 2024 | By: | /s/ Katie Field | |
| Name: | Katie Field | ||
| Title: | Interim Chief Executive Officer and Director |
2
Exhibit 99.1
AKANDA CORP ANNOUNCES SETTLEMENT AGREEMENT WITHFORMER CEO TEJINDER VIRK
London, UK May 13, 2024 –Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), today announced a settlement agreement with former chief executive officer and director, Tejinder Virk, concluding a series of disputes that commenced following Mr. Virk’s resignation on February 3, 2023.
The settlement resolves all outstanding claims and disputes Mr. Virk had with the Company and its subsidiaries, providing a clear path forward and allowing all parties to focus on their future endeavors without the overhang of previous disagreements.
Katharyn Field, Chief Executive Officer of Akanda Corp, commented, “Our decision to settle is in the best interest of everyone involved. It allows us to continue dedicating our resources and attention to strategic priorities without distraction.”
The agreement includes a waiver of all claims related to Mr. Virk’s employment and its termination. Any queries relating to the settlement should be addressed to the Company’s UK counsel, Paul McAleavey of Girlings Solicitors LLP.
About Akanda Corp.
Akanda is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. Akanda’s portfolio includes CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. The Company’s seed-to-patient supply chain also includes partnerships Cellen Life Sciences’ Leva Clinic, one of the first fully digital pain clinics in the UK. Akanda also acquired the right to develop a Canadian farming property in British Columbia, including farming land and related operations and licenses. The Company plans to develop THC and cannabinoid (CBD) facilities at this site.
Connect with Akanda: Email | Website | LinkedIn | Twitter | Instagram
Investor Contact
Cautionary Note Regarding Forward-LookingInformation and Statements
This press release contains certain “forward-looking information” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Akanda’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Akanda’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved” and similar expressions and include statements regarding the timing and completion of the proposed offering. Forward-looking information may relate to anticipated events or results including, but not limited to business strategy, product development and sales and growth plans. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Akanda does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.